Sort
82,697 grants matching “vaccine development”
Establish a Public Private Partnership for COVID19 Research
$5,898,134David N. Wholley · Foundation For The Nih · OT2 · FY2021 · OD
Anti-HIV Broadly Neutralizing Monoclonal Antibody (bnAbs) Drug Substance (DS) Clinical Trial Material Production and Release
$5,897,683David Lindsay · Leidos Biomedical Research, Inc. · N01 · FY2019 · CA
Clinical Research Support for the CCR
$5,885,451Thomas A Misteli · Division Of Basic Sciences - Nci · ZID · FY2023 · CA
Core D: Animal models and vaccine evaluation
$5,867,641Thomas William Geisbert · University Of Washington · U19 · FY2024 · AI
Center for Human Immunology
$5,867,519James Cherry · National Institute Of Allergy And Infectious Diseases · ZIC · FY2025 · AI
Design and testing picornavirus vaccine candidates
$5,864,929Raul Andino · Vanderbilt University Medical Center · U19 · FY2024 · AI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine
$5,862,877Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2009 · AI
Dengue Human Immunology Project Consortium (DHIPC)
$5,858,923Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2019 · AI
DCTD Biopharmaceutical Development
$5,855,121David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA
NEW HORIZONS IN THE PREVENTION AND TREATMENT OF FOOD ALLERGY
$5,854,959Robert A Wood · Johns Hopkins University · UM2 · FY2020 · AI
NEW HORIZONS IN THE PREVENTION AND TREATMENT OF FOOD ALLERGY
$5,854,959Robert A Wood · Johns Hopkins University · UM2 · FY2019 · AI
NEW HORIZONS IN THE PREVENTION AND TREATMENT OF FOOD ALLERGY
$5,854,958Robert A Wood · Johns Hopkins University · UM2 · FY2021 · AI
NEW HORIZONS IN THE PREVENTION AND TREATMENT OF FOOD ALLERGY
$5,854,685Robert A Wood · Johns Hopkins University · UM2 · FY2018 · AI
Laboratory Animal Research Support & Model Development
$5,852,957Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
DEVELOPMENT OF RICIN VACCINE FORMULATION
$5,841,498Robert Brey · Soligenix, Inc. · N01 · FY2014 · AI
Identification of HLA class II T cell epitopes from Mycobacterium tuberculosis
$5,839,818La Jolla Institute For Immunology · N01 · FY2009 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS
$5,828,394Matthew Johnson · Duke University · N01 · FY2021 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$5,828,214Judith S. Currier · University Of California Los Angeles · UM1 · FY2021 · AI
B-cell Biology of Mucosal Immune Protection from SIV Challenge
$5,826,449Eric Hunter · Emory University · U19 · FY2012 · AI
SUPPORT CONTRACT FOR THE NTP INTERAGENCY CENTER/VALIDATION OF ALT METHODS
$5,824,943David Allen · Integrated Laboratory Systems, Llc · N01 · FY2009 · ES
Development of Mutivalent Filovirus (Ebola and Marburg) Vaccines
$5,818,745Integrated Biotherapeutics, Inc. · N01 · FY2008 · AI
HIV Vaccine Studies
$5,817,888Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
NHP Major Histocompatibility Complex Gene Discovery and Typing Technology
$5,815,265Daniel E Geraghty · Fred Hutchinson Cancer Research Center · N01 · FY2011 · AI
B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection
$5,814,430Eric Hunter · Emory University · UM1 · FY2022 · AI
BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral Eradication
$5,797,611Douglas F Nixon · Weill Medical Coll Of Cornell Univ · UM1 · FY2018 · AI